Comparison of Tc9m-PSMA scan and MRI in glioblastoma

Evaluating the findings of Tc99m-PSMA scan in glioblastoma in comparison to MRI

Status

Recruiting

Phases

Phase 3

Study type

Observational

Source

IRCT

Registry ID

IRCT20190623043986N2

Enrollment

Registered

2024-10-23

Start date

2024-11-05

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma. Malignant neoplasm of brain

Interventions

Intervention group: For the Tc99m-PSMA scan, 20 mCi Tc99m-labeled PSMA radiotracer was intravenously injected and after 3 hours, SPECT/CT images were obtained from the head region. Metabolically activ

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with glioblastoma Patients with recent MRI (less than 1 month) Those who consent to participate in the study

Exclusion criteria

Exclusion criteria: Unstable condition Poor cooperation of patients for image acquisition

Design outcomes

Primary

Measure	Time frame
Tumor to background ratio. Timepoint: One time when the scan performed. Method of measurement: Volumetric analysis software in SPECT.;Metabolically active volume of tumor. Timepoint: One time when the scan performed. Method of measurement: Volumetric analysis software in SPECT.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Ghaedian

Shiraz University of Medical Sciences

tghaedian@gmail.com+98 71 3612 5315

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026